Merck (MRK) Inventory (2009 - 2026)

Merck (MRK) has reported Inventory for 18 consecutive years, with $6.2 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Inventory fell 5.97% year-over-year to $6.2 billion in Q2 2026; TTM through Jun 2026 was $6.2 billion, a 5.97% decrease from a year earlier, with the FY2025 full-year figure at $6.7 billion, up 8.99% from the prior year.
• Inventory was $6.2 billion for Q2 2026 at Merck, down from $6.5 billion in the prior quarter.
• Over five years, Inventory peaked at $6.7 billion in Q4 2025 and troughed at $5.5 billion in Q2 2022.
• A 5-year average of $6.2 billion and a median of $6.2 billion in 2025 frame the typical range for Inventory.
• Across the five-year window, Inventory decreased 9.81% in 2022 and climbed 11.04% in 2024, its largest moves.
• Over 5 years, Inventory stood at $5.9 billion in 2022, then gained by 7.56% to $6.4 billion in 2023, then declined by 3.92% to $6.1 billion in 2024, then climbed by 8.99% to $6.7 billion in 2025, then fell by 6.77% to $6.2 billion in 2026.
• The last three Inventory figures came in at $6.2 billion (Q2 2026), $6.5 billion (Q1 2026), and $6.7 billion (Q4 2025), per Business Quant data.